<?xml version="1.0" encoding="UTF-8"?>
<p>Wu et al.
 <xref rid="CIT0052" ref-type="bibr">
  <sup>52</sup>
 </xref> extracted antroquinonol (
 <bold>15</bold>), a novel compound with anti-inflammatory activities, from the mycelium of 
 <italic>Antrodia camphorata</italic>
 <xref rid="CIT0053" ref-type="bibr">
  <sup>53</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0054" ref-type="bibr">
  <sup>54</sup>
 </xref>. Ho et al.
 <xref rid="CIT0006" ref-type="bibr">
  <sup>6</sup>
 </xref> measured the inhibitory effect of Antroquinonol on various of tumours such as human lung cancer, liver cancer, and leukaemia. Antroquinonol plays a major role in interrupting the function of Ras and Ras-related GTP-binding proteins by inhibiting the activity of FTase and GGTase in cancer cells, ultimately resulting in cell death. At present, antroquinonol is in the phase 2 clinical trials in patients with non-small cell lung cancer
 <xref rid="CIT0006" ref-type="bibr">
  <sup>6</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0055" ref-type="bibr">
  <sup>55</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0056" ref-type="bibr">
  <sup>56</sup>
 </xref>.
</p>
